Basic information Safety Related Supplier

ChemicalBook Product Catalog API Blood System Drugs Prasugrel Hydrochloride

1/1

Prasugrel Hydrochloride NEW

$30.00 25mg

$39.00 50mg

$54.00 100mg

Min. Order
Purity99.79%
Cas No389574-19-0
Supply Ability10g
Update time2025-11-10

TargetMol Chemicals Inc.

TargetMol Chemicals Inc.

VIP6Y

United States

United States

show more

Enterprise Verified

Business Bank account Basic Contact Infomation Business Address Trade Company

Chemical Properties

Product Name	Prasugrel Hydrochloride
CAS No	389574-19-0
EC-No
Min. Order
Purity	99.79%
Supply Ability	10g
Release date	2025/11/10

Product Introduction

Bioactivity

Name	Prasugrel Hydrochloride
Description	Prasugrel Hydrochloride (LY 640315 Hydrochloride) is a piperazine derivative and pletelet aggregation inhibitor that is used to prevent thrombosis in patients with acute coronary syndrome.
In vivo	Prasugrel significantly inhibits arterio-venous (AV) shunt and electrically induced arterial thrombosis in single dose ranges of 0.3 to 3 mg/kg and of 0.3 and 1 mg/kg/day for multiple doses. These doses are similar to doses with inhibition of platelet activation via P2Y12 receptors, suggesting that the protective effects of prasugrel in these cerebral infarction and peripheral arterial occlusive disease models reflect P2Y12 inhibitions on platelets by prasugrel's active metabolite. Prasugrel also significantly prevents progression of peripheral vascular lesions[1].
Storage	keep away from moisture,keep away from direct sunlight \| Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice/Shipping at ambient temperature.
Solubility Information	H2O : < 1 mg/mL (insoluble or slightly soluble) 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (4.88 mM), Sonication is recommended. DMSO : 43 mg/mL (104.9 mM), Sonication is recommended. Ethanol : 9 mg/mL (21.96 mM), Sonication is recommended.
Keywords	Prasugrel Hydrochloride \| Prasugrel \| platelet \| PCR-4099 \| PCR4099 \| PCR 4099 \| P2YReceptor \| P2Y12 \| P2Y Receptor \| P2Y \| LY-640315 Hydrochloride \| LY640315 Hydrochloride \| LY-640315 \| LY640315 \| Effient Hydrochloride \| antiplatelet \| aggregation \| active
Inhibitors Related	Clopidogrel \| Prasugrel \| PSB-16133 sodium \| Uridine 5′-diphosphoglucose disodium salt \| Regrelor disodium \| (±) Clopidogrel hydrogen sulfate \| Clopidogrel hydrogen sulfate \| Uridine-5'-diphosphate disodium salt \| N6-(4-Hydroxybenzyl)adenosine \| Ticagrelor \| Diquafosol tetrasodium \| cangrelor tetrasodium
Related Compound Libraries	Bioactive Compound Library \| Membrane Protein-targeted Compound Library \| EMA Approved Drug Library \| Anti-Cancer Clinical Compound Library \| Drug Repurposing Compound Library \| Inhibitor Library \| NO PAINS Compound Library \| FDA-Approved Drug Library \| Anti-Cancer Approved Drug Library \| Bioactive Compounds Library Max \| GPCR Compound Library \| Anti-Cancer Drug Library

show more

Company Profile Introduction

You may like

Recommended supplier

MSDS|CAS|CAS DataBase|Pricacy|Terms|About Us|New Products| Contact us|Computer Version
Chemical Book